基因敲除
基因沉默
下调和上调
细胞凋亡
细胞生物学
体内
化学
小干扰RNA
氧化应激
谷氨酸受体
磷酸化
体外
癌症研究
GPX4
程序性细胞死亡
心肌梗塞
信号转导
转染
药理学
医学
活性氧
结合珠蛋白
细胞
细胞培养
作者
Wei Liao,L L Zhang,Shunjun Liu,Renxiang Zhou,Di Wu,Hongwei Yan,ZiYou Liu
标识
DOI:10.1096/fj.202504897r
摘要
ABSTRACT Ischemia–reperfusion injury severely impacts the heart and brain, and although ferroptosis is a key therapeutic target, the role of interleukin‐6 in regulating ferroptosis during cardiac and cerebral I/R remains unclear. In vitro oxygen–glucose deprivation (OGD)‐treated PC12 and H9C2 cells and in vivo myocardial I/R mice and MCAO rats were used to model ischemic injury. IL6 expression was silenced using siRNA or lentivirus, whereas IL‐6 overexpression was achieved using an IL6 overexpression plasmid. Cells or animals were subsequently treated with glutamate (Glu), haptoglobin (HP), ferrostatin‐1 (Fer‐1), or colivelin, a JAK2/STAT3 pathway agonist. IL6 knockdown significantly suppressed OGD‐induced ferroptosis by upregulating GPX4 and SLC7A11, thereby improving cell survival and reducing ROS and Fe 2+ accumulation. IL6 silencing attenuated OGD‐induced apoptosis, effects that were significantly abolished by Glu or HP. In myocardial I/R and MCAO models, IL6 knockdown preserved cardiac function, reduced cerebral infarction, alleviated oxidative stress, and mitigated ferroptosis, whereas Glu or HP co‐treatment reversed these benefits. Mechanistically, IL6 silencing inhibited JAK2/STAT3 activation, while colivelin treatment reinstated pathway phosphorylation and ferroptosis. IL6 downregulation alleviates cardiac and cerebral I/R injuries by suppressing ferroptosis through regulation of the JAK2/STAT3 pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI